Clinical Trial Detail

NCT ID NCT03614728
Title Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Azacitidine + GSK3326595

GSK3326595

Age Groups: adult senior

Additional content available in CKB BOOST